RenaissanceRe Holdings Ltd. (RNR) quarterly income statement — complete revenue, gross profit & net income history
| Revenue | 2.19B | 2.92B | 3.19B | 3.19B | 3.45B | 2.28B | 3.97B | 2.82B | 2.59B | 3.22B | 1.83B | 1.85B |
| Revenue Growth % | -36.43% | 28.32% | -19.72% | 13.15% | 33.55% | -29.34% | 117.41% | 52.58% | 17.75% | 59.49% | 42.06% | 114.7% |
| Medical Costs & Claims | 0 | 951.14M | 1.54B | 1.68B | 3.39B | 2.16B | 2.06B | 1.95B | 1.8B | 1.57B | 1.29B | 1.35B |
| Medical Cost Ratio % | 0% | 32.53% | 48.3% | 52.87% | 98.22% | 94.87% | 52.01% | 69.39% | 69.51% | 48.81% | 70.53% | 73.35% |
| Gross Profit | 0 | 1.97B | 1.65B | 1.5B | 61.47M | 116.86M | 1.9B | 861.99M | 788.25M | 1.65B | 537.82M | 491.77M |
| Gross Margin % | 0% | 67.47% | 51.7% | 47.13% | 1.78% | 5.13% | 47.99% | 30.61% | 30.49% | 51.19% | 29.47% | 26.65% |
| Gross Profit Growth % | -100% | 1588.36% | -13.5% | 74.19% | -92.2% | -92.92% | 254.04% | 75.28% | -18.07% | 110.08% | 148.86% | 336.56% |
| Operating Expenses | 0 | 709.35M | 166.52M | 160.98M | 132.25M | 199.99M | 169.43M | 154.22M | 154.41M | 216.55M | 112M | 111.06M |
| OpEx / Revenue % | 0% | 24.26% | 5.23% | 5.05% | 3.83% | 8.78% | 4.27% | 5.48% | 5.97% | 6.71% | 6.14% | 6.02% |
| Depreciation & Amortization | 0 | 0 | -6.72M | 5.42M | 3.73M | 6.85M | 225.62M | 9.96M | 16.03M | -13.69M | -47.84M | -40.28M |
| Combined Ratio % | 0% | 56.78% | 53.52% | 57.93% | 102.05% | 103.65% | 56.28% | 74.87% | 75.48% | 55.52% | 76.67% | 79.37% |
| Operating Income | 13.75K | 1.26B | 1.48B | 1.34B | -70.79M | -83.13M | 1.73B | 707.77M | 633.84M | 1.43B | 425.82M | 380.72M |
| Operating Margin % | 0% | 43.22% | 46.48% | 42.07% | -2.05% | -3.65% | 43.72% | 25.13% | 24.52% | 44.48% | 23.33% | 20.63% |
| Operating Income Growth % | 100.02% | 1620.21% | -14.65% | 89.41% | -111.17% | -105.8% | 307.37% | 85.9% | -27.08% | 105.27% | 135.9% | 228.07% |
| EBITDA | 13.75K | 1.3B | 1.47B | 1.35B | -67.05M | -76.28M | 1.96B | 717.73M | 649.87M | 1.42B | 377.99M | 340.43M |
| EBITDA Margin % | 0% | 44.29% | 46.27% | 42.24% | -1.94% | -3.35% | 49.4% | 25.49% | 25.14% | 44.05% | 20.71% | 18.45% |
| Interest Expense | 31.79M | 31.39M | 30.58M | 31.79M | 27.09M | 23.25M | 23.81M | 23.61M | 23.1M | 23.2M | 22.95M | 14.89M |
| Non-Operating Income | 0 | -31.39M | -30.58M | -31.79M | -27.09M | -23.25M | -23.81M | -23.61M | -23.1M | -23.2M | -22.95M | -14.89M |
| Pretax Income | 548.81M | 1.26B | 1.48B | 1.34B | -70.79M | -83.13M | 1.73B | 707.77M | 633.84M | 1.43B | 425.82M | 380.72M |
| Pretax Margin % | 25% | 43.22% | 46.48% | 42.07% | -2.05% | -3.65% | 43.72% | 25.13% | 24.52% | 44.48% | 23.33% | 20.63% |
| Income Tax | -32.98M | 116.13M | 148.86M | 176.87M | -45.52M | -63.91M | 102.01M | -20.85M | 15.37M | -554.21M | 9.29M | 5.94M |
| Effective Tax Rate % | -6.01% | 9.19% | 10.05% | 13.19% | 64.31% | 76.88% | 5.88% | -2.95% | 2.43% | -38.64% | 2.18% | 1.56% |
| Net Income | 581.8M | 760.48M | 916.51M | 835.35M | 169.99M | -189.66M | 1.18B | 503.89M | 373.64M | 1.59B | 202.83M | 199.87M |
| Net Margin % | 26.51% | 26.01% | 28.77% | 26.22% | 4.92% | -8.32% | 29.8% | 17.89% | 14.45% | 49.17% | 11.11% | 10.83% |
| Net Income Growth % | 242.25% | 500.97% | -22.49% | 65.78% | -54.5% | -111.96% | 482.99% | 152.11% | -34.78% | 246.99% | 124.84% | 163.24% |
| EPS (Diluted) | 6.57 | 16.75 | 19.40 | 17.20 | 3.27 | -3.89 | 22.62 | 9.41 | 6.94 | 30.42 | 3.80 | 8.15 |
| EPS Growth % | 100.92% | 530.59% | -14.24% | 82.78% | -52.88% | -112.79% | 495.26% | 15.46% | -64.48% | 88.24% | 113.69% | 208.23% |
| EPS (Basic) | 6.60 | 16.75 | 19.47 | 17.25 | 3.29 | -3.89 | 22.68 | 9.44 | 6.96 | 30.50 | 3.81 | 8.17 |
| Diluted Shares Outstanding | 42.63M | 44.87M | 47.27M | 47.9M | 51.1M | 50.43M | 51.1M | 51.81M | 51.83M | 51.07M | 50.36M | 45.99M |